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Abstract
Herein, we report the effects of graphene oxides on human fibroblast cells and mice with the aim of investigating
graphene oxides’ biocompatibility. The graphene oxides were prepared by the modified Hummers method and
characterized by high-resolution transmission electron microscope and atomic force microscopy. The human
fibroblast cells were cultured with different doses of graphene oxides for day 1 to day 5. Thirty mice divided into
three test groups (low, middle, high dose) and one control group were injected with 0.1, 0.25, and 0.4 mg
graphene oxides, respectively, and were raised for 1 day, 7 days, and 30 days, respectively. Results showed that the
water-soluble graphene oxides were successfully prepared; graphene oxides with dose less than 20 μg/mL did not
exhibit toxicity to human fibroblast cells, and the dose of more than 50 μg/mL exhibits obvious cytotoxicity such
as decreasing cell adhesion, inducing cell apoptosis, entering into lysosomes, mitochondrion, endoplasm, and cell
nucleus. Graphene oxides under low dose (0.1 mg) and middle dose (0.25 mg) did not exhibit obvious toxicity to
mice and under high dose (0.4 mg) exhibited chronic toxicity, such as 4/9 mice death and lung granuloma
formation, mainly located in lung, liver, spleen, and kidney, almost could not be cleaned by kidney. In conclusion,
graphene oxides exhibit dose-dependent toxicity to cells and animals, such as inducing cell apoptosis and lung
granuloma formation, and cannot be cleaned by kidney. When graphene oxides are explored for in vivo
applications in animal or human body, its biocompatibility must be considered.
Introduction
In recent years, a lot of engineered nanomaterials are
fabricated endlessly and investigated for their applica-
tions [1-6], and nanomaterials’ biosafety has caused
more and more attention from governments and scien-
tific communities [7,8]. For example, carbon nano-
tubes, as the special carbon nanomaterials, have been
investigated for their effects on the cells, animals and
environment, and evaluated for their biosafety [9-13].
Graphene is a flat monolayer of carbon atoms tightly
packed into a two-wdimensional (2D) honeycomb lat-
tice and is a basic building block for graphitic materi-
als of all other dimensionalities with unique physical,
chemical, and mechanical properties [14,15]. Graphene
and graphene oxide (GO) layers have become a hot-
spot so far and have been actively investigated to build
new composite materials [16,17]. These novel nanoma-
terials have great potential in applications such as
electrochemical devices [18,19], energy storage [20,21]
catalysis [22], adsorption of enzyme [23], cell imaging
and drug delivery [24], as well as biosensors [25] How-
ever, up to date, no report is closely associated with
biosafety of GO in cells or live biosystems. Here we
are the first to report the effects of GO on human nor-
mal cells and mice, our results show that GO exhibits
dose-dependent toxicity to cells and mice, which highly
suggests that the biocompatibility of GO must be
considered when the GO is applied for biomedical
engineering.
Experiments
Synthesis and Characterization of GO
Graphene oxide (GO) was prepared from natural gra-
phite powder by the modified Hummers method [26].
Graphite (2 g 500 mesh) and sodium nitrate (1 g) were
added to a 250-mL flask at 0°C. Concentrated H2SO4
(50 mL) was then added slowly with stirring below 5°C.
The mixture was stirred for 30 min and 0.3 g of
KMnO4 was added in small portions below 10°C. The
reaction mixture was stirred for an additional 30 min
and 7 g of KMnO4 was added to the mixture respec-
tively over 1 h below 20°C. After the temperature of the
* Correspondence: swguo@sjtu.edu.cn; dxcui@sjtu.edu.cn
† Contributed equally
National Key Laboratory of Nano/Micro Fabrication Technology, Key
Laboratory for Thin Film and Microfabrication of Ministry of Education,
Institute of Micro-Nano Science and Technology, Shanghai Jiao Tong
University, 800 Dongchuan Road, Shanghai, 200240, People’s Republic
of China.
Wang et al. Nanoscale Res Lett 2011, 6:8
http://www.nanoscalereslett.com/content/6/1/8
© 2010 Wang et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited.
mixture warmed to 35 ± 3°C and stirred for 2 h, 90 mL
of water was slowly dripped into the paste, causing an
increase in temperature to 70°C and the diluted suspen-
sion was stirred at this temperature for another 15 min.
Then, it was further treated with a mixture of H2O2
(30%, 7 mL) and water (55 mL). The resulting suspen-
sion turned bright yellow, and the warm suspension
(about 40°C) was filtered, resulting in a yellow–brown
filter cake. The cake was washed for three times with a
warm solution of 3% aqueous HCl (150 mL), followed
by drying at 40°C for 24 h in vacuo. Finally, the GO was
obtained by ultrasonication of as-made graphite oxide in
water for 1 h. The resulting homogeneous yellow–
brown dispersion was tested to be stable until now.
GO was analyzed by the FT-IR technique showed the
presence of GO, using Fourier transform infrared
(EQUINOX 55, Bruker, Germany) spectrometer.
Furthermore, the structure and the texture of GO were
observed by transmission electron microscopy (TEM)
and AFM (Figure 2), which are JEOL JEM-2010 TEM
and Nanoscope MultiMode SPM (Veeco, American).
Effects of GO on Human Fibroblast Cells
In order to investigate the cytotoxicity of GO in vitro,
we chose human fibroblast cell (HDF) as the target cells
to evaluate the cell viability and proliferation by CCK8
assays. Every well in the 96-well plate was planted 5,000
cells and incubated in a humidified 5% CO2 balanced air
incubator at 37°C for 24 h. Except from control wells,
the contents in the remaining wells were added into
medium with GO and the final concentrations were 5,
10, 20, 50, 100 μg/mL, respectively, next continued to
culture from day 1 to day 5, we measured the absor-
bency using the Thermo multiskan MK3 ELISA plate
reader according to the protocol of CCK8 assay and cal-
culated the survival rate of cells. The survival rate of
cells can be calculated by the following equation:





( ) ( ) ×A A570 570 100
(1)
where A570(sample) is absorbance intensity at 570 nm in
the presence of GO, and A570(control) is absorbance
intensity at 570 nm in the absence of GO.
The cell attachment assay was performed as previously
described [27]. Essentially, 6-well plates were coated with
fibrinogen (5 μg/mL) and vitronectin (1.5 μg/mL) in
DPBS. Cells were harvested, washed three times with
serum-free minimal essential medium with Eargle’s salt
and resuspended in attachment solution (calcium- and
magnesium-free Hanks’ balanced salt solution, 20 mM
HEPES, 1 mg/mL heat-inactivated BSA, 1 mM CaCl2 and
1 mM MgCl2). Cells (1 × 10
4) were added to each well
and allowed to culture for 1–5 days at 37°C in a humidi-
fied 5% CO2 incubator. These plates of respective 5, 10,
20, 50 and 100 μg/mL GO-treated cells were cultured for
1–5 days, and 1 control plate was set up (1 × 104 cells
were added into each well, which was treated with 0.5%
DMSO vehicle and allowed to culture for 1–5 days at
37°C in a humidified 5% CO2 incubator) and were centri-
fuged for 10 min at the speed of 4,000 rpm. Unattached
cells were washed with Hanks’ balanced salt solution.
The number of remaining attached cells after centrifuga-
tion was quantified spectrophotometrically at 405 nm in
triplicate [28]. Cell adhesion ability (%) = the number of
GO-treated adhesive cells/the number of control adhe-
sive cells.
Human fibroblast cells (HDF) were treated for 5 days
with different concentrations of GO: 5, 10, 20, 50, and
100 μg/mL. After incubation, cells were lysed in protein
lysis buffer. Equal amounts of sample lysate were sepa-
rated by sodium dodecylsulfatepolyacrylamide gel elec-
trophoresis (SDS–PAGE) and electrophoretically
transferred onto polyvinylidene difluoride (PVDF) mem-
branes (Millipore). The membrane was blocked with
0.1% BSA in TBST buffer and incubated overnight at
4°C with specific primary antibodies. Subsequently, the
membrane was washed with TBST buffer and incubated
with horseradish peroxidase-conjugated secondary anti-
bodies. Enhanced chemiluminescence kits were used
(Amersham, ECL kits) [29]. In order to confirm whether
GO can stimulate HDF cells secrete small molecular
proteins, HDF cells were cultured for 5 days in essential
medium without 10% fetal calf serum with the aim of
excluding mistaking fetal calf serum proteins as secreted
small molecular proteins.
HDF was treated with 20 μg/mL GO and cultured in
a humidified 5% CO2 balanced air incubator at 37°C
for 24 h, then fixed cells with 2.5% glutaraldehyde
solution and embedded with epoxy resin, finally made
the ultrathin cell specimen and observed the specimen
with TEM.
Effects of GO on Mice
All animal experiments performed in compliance with the
local ethics committee. Kunming mice (female, 28–30 g,
4–5 weeks old) were obtained from the Shanghai LAC
Laboratory Animal Co. Ltd., Chinese Academy of Sciences
(Shanghai, China) and housed in positive-pressure air-
conditioned units (25°C, 50% relative humidity) on a
12:12-h light/dark cycle. The mice were allowed to accli-
mate at this facility for 1 week before being used in the
experiment. Each mouse was exposed to the GO suspen-
sion via a single tail vein injection. The mice were killed at
1, 7, and 30 days post exposure, and their organs, includ-
ing heart, liver, spleen, stomach, kidneys, lungs and brain,
were collected. For conventional histology, tissues were
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collected immediately after killing, fixed in 10% formalde-
hyde, embedded in paraffin, cut into 20-μm-thick section,
stained with hematoxylin and eosin, and examined by light
microscopy. Three mice were used for negative control.
Statistical Analysis
Each experiment was repeated three times in duplicate.
The results were presented as mean ± SD.
Statistical differences were evaluated using the t-test
and considered significance at P < 0.05.
Results and Discussion
Characterization of GO
The prepared GO was water-soluble, black, and dispersed
well. As shown in Figure 1, the spectrum of FT-IR of GO
showed that the peak at 3,395 cm-1 attributes to O–H
stretching vibration, the peak at 1,726 cm-1 attributes to
C=O stretching vibration, the peak at 1,426 cm-1 attri-
butes to deformation of O–H, the peak at 1,226 cm-1
attributes to vibration of C–O (epoxy), and the peak at
1,052 cm-1 attributes to vibration of C–O (alkoxy). AFM
image of GO showed that the GO sheet is flat and
smooth, and the height of GO sheet is about 1 nm, indi-
cating the mono-layer GO sheet was successfully
prepared. The TEM image of GO also confirmed the GO
existed in the sheet-like shapes. Therefore, water-soluble
graphene oxides were successfully prepared.
Effects of GO on Human Fibroblast (HDF) Cells
Regarding the effects of GO on HDF cells, as shown in
Figure 2a, GO below 20 μg/mL exhibited low cytotoxi-
city, the cell survival rate is more than 80%, above
50 μg/mL exhibited obvious cytotoxicity such as
decreasing cell survival rate, inducing cell floating and
cell apoptosis. As the cell culture day increased, the sur-
vival rate of cells decreased correspondingly, highly
dependent on GO dose and culture time. As shown in
Figure 2b, GO was indeed internalized by cells and
mainly located inside cytoplasm such as lysosomes,
mitochondrion, and endoplasm. We also observed that,
as the culture time increased, the amount of GO inside
HDF cells increased accordingly, and lot of GO
appeared as black dots scattered in the cell cytoplasm
around cell nuclear, a few GO located inside nucleus.
Figure 1 Characterization of graphene oxides: a AFM image of GO, b TEM image of GO, c FT-IR spectrum of GO.
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Effects of GO on Cell Adhesive Proteins
The adhesive ability of GO-treated HDF cells can be
evaluated with the ratio of GO-treated adhesive cell
number to the control adhesive cell number after centri-
fuge. As shown in Figure 3, the cell adhesive ability
decreased markedly with the increase in GO concentra-
tion and culture time. Western blot results showed that,
comparing with normal cells, the expression levels of
laminin, fibronectin, FAK, and cell cycle protein cyclin
D3 in the HDF cells treated with GO were markedly
decreased, and their expression levels in HDF cells cul-
tured with GO decreased gradually as the amount of
GO increased as shown in Figure 4, the b-actin protein
expression remained unchanged in each case. There is a
significant difference (P < 0.05) between GO-treated
groups and normal control group.
Effects of GO on Cell Morphology
Microscopic observation of GO-treated HDF cells
showed that, compared with control cells as shown in
Figure 5a, some HDF cells rounded up, detached from
the culture plates and displayed morphological changes
characteristic of apoptosis after 24 h of incubation as
the dose of GO in the medium reached 100 μg/mL as
shown in Figure 5b, HDF cells cultured with 20 μg/mL
GO for 72 h exhibited features characteristic of apopto-
sis such as membrane vesicles, fragmentation and
unclear cell boundary, apoptotic cells formed nodular
structure encapsulating GO as shown in Figure 5c. HDF
cells cultured with 5 μg/mL GO for 100 h showed nor-
mal cell morphology except to rough cell surface as
shown in Figure 5d.
Effects of GO on Lifespan of Mice
Regarding the effects of GO on mice, we used tail vein
injection pathway to evaluate the in vivo toxicity. The
mice were injected with 0 mg (control group), 0.1 mg
(low dose group, LD), 0.25 mg (medium dose group,
Figure 3 Western blot analysis of adhesion proteins in HDF
cells cultured with different concentrations of GO for 5 days.
Lanes 1–6 show the expression levels of proteins in HDF cells
treated with GO with the following concentrations: 100, 50, 20, 10,
5, 0 μg/mL, respectively.
Figure 4 GO-treated HDF cell adhesion ability measured by
centrifugation method. The percentage of adhesive cells
decreased with the increase in GO concentration and culture time.
Figure 2 Effects of GO on human fibroblast cells: a the HDF survival rate at different concentrations of GO and different culture time,
b TEM picture of location of GO inside HDF cells as shown by the arrows.
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MD), and 0.4 mg (high dose group, HD) GO per mouse.
After 1 day, 1 week, and 1 month exposure, the mice
were killed by the method of cervical vertebra displace,
and then used histopathology to evaluate inflammation
degree of the mouse organs.
Injection dose of GO at 0.1 and 0.25 mg per mouse
did not cause mortality of exposed mice, and showed no
obvious clinical toxic signs, and the body weight of trea-
ted mice accordingly increased with the raise time
increasing. However, 4 of 9 mice treated with 0.4 mg
per mouse died (1/3 in the 1-day group, 1/3 in the
7-day group and 2/3 in the 30-day group). All deaths
occurred 1–7 days after injection of the GO. The deaths
were generally preceded by lethargy, inactivity, and
body-weight losses. Histopathology of lung tissues
showed that major airways of four mice were mechani-
cally blocked by the GO conglomeration, which led to
suffocation in 15% of the GO-exposed mice, and was
not evidence of pulmonary toxicity of GO. In addition,
the survival mice treated with 0.4 mg of GO for 24 h
appeared weakness and lost 10% of body weights within
first week, this symptoms disappeared after one week, as
evidenced by subsequent normal eating behavior and
weight increase.
Effects of GO on Important Organs
We also investigated the effects of GO on organs of mice.
We learn from the pathology and light micrograph that
the GO accumulations were primarily in the lungs, liver,
and spleen. There were obvious chronic toxicity res-
ponses occurring in the lungs and liver after tail vein
injection. Histopathological analysis revealed that pul-
monary exposures to GO produced a dose-dependent
lung inflammatory response characterized by neutrophils
and foamy alveolar macrophage accumulation. Figure 6
showed the light micrograph of lung tissues from mice
Figure 5 Apoptosis of HDF cells induced by GO: a normal HDF cells, showing normal morphological cells, b morphological changes of
HDF cells cultured with 100 μg/mL GO for 1 day, cells appear inner vacuole and apoptotic bodies showing apoptotic characteristics,
c morphology of HDF cells cultured with 20 μg/mL GO for 3 days, showing cell have unclear boundary, membrane vesicles and
fragmentation, the arrow showing apoptotic cells formed nodular structure encapsulating GO, d morphology of HDF cells cultured
with 5 μg/mL GO for 5 days, showing normal cell morphology.
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exposed to different doses of GO for 7 days, clearly
showed that the treated mice exhibited a dose-dependent
series of granulomas. With the increase in GO dose, the
toxicity reaction of the lung of mice becomes more and
more severe. For example, GO induced dose-dependent
epithelioid granulomas and, in some cases, interstitial
inflammation in the mice. Large amount of inflammation
cells was infiltrated in lung alveolus interstitium; the
alveolar septa became thicker and some lung alveoli were
cracked.
Figure 7 is the light micrograph of lung tissues from
mice exposed to GO of 0.1 mg by tail vein injection at
different exposure time. The early development of lesions
was first observed at 7 days, wherein the lesions sur-
rounded the GO, and this was associated with a nonuni-
form, diffuse pattern of GO particulate deposition in the
lung. Subsequently, at 30 days, a diffuse pattern of multi-
focal macrophage-containing granulomas was presented.
It was interesting to note that few lesions existed in some
lobes, while other lobes contained several granulomatous
lesions. This was likely due to the nonuniform deposition
pattern following GO instillation. At higher magnifica-
tion, one could discern the discrete multifocal mononuc-
lear granulomas centered around the GO.
Figure 6 The light micrograph of lung tissues about rats exposed to different dose graphene sheets for 7 days: a control: 0 mg,
b 0.1 mg, c 0.25 mg, d 0.4 mg (magnification = ×200).
Figure 7 The light micrograph of lung tissues from mice exposed to GO of 0.1 mg at different exposure time: a 7 days, b 30 days
(magnification = ×200).
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In order to observe the high accumulation levels and
to assess the biological effects of GO in mice organs,
ultrathin sections were prepared from the harvested
mice lungs and liver for TEM imaging. Figure 8 showed
the TEM images of the ultrastructural features of the
lung and live tissues exposed to GO. The GO still
remained in the lungs after 1 month, some in capillary
vessel and some in cytoplasmic vacuoles of lung tissues
(Figure 8a). There were a lot of inflammation cells
appeared in the wall of lung vacuole, such as multinuc-
lear giant cells and acidophilic cells. The ultrastructural
features of most cells appeared pathological changes. As
shown in Figure 8b, the GO was found to be entrapped
in the phagosome of a hepatic macrophage.
Regarding the biodistribution of GO in mice, as we
observed, GO mainly located in lung, liver and spleen,
no GO was found in the brain tissues, which highly sug-
gests that GO cannot get through blood–brain barrier.
Few GO was observed in kidney of mice, which highly
suggests that GO is very difficult to be exited out by
pathway of kidney, we speculate that GO mainly is
expelled out by liver secretion into bile tract system.
The Potential Mechanism of Effects of GO on Human Cells
As mentioned earlier, we clearly observed that graphene
oxides with dose of less than 20 μg/mL did not exhibit
toxicity to human fibroblast cells, and the dose of more
than 50 μg/mL exhibits obvious cytotoxicity such as
decreasing cell adhesion, inducing cell apoptosis, enter-
ing into lysosomes, mitochondrion, endoplasm, and cell
nucleus. Similar phenomena were also observed in other
cell lines such as human gastric cancer MGC803,
human breast cancer MCF-7, MDA-MB-435, and liver
cancer HepG2 cell lines (data not shown), which highly
suggest that GO exhibits obvious toxicity to human nor-
mal cells or tumor cells. According to our results, we
suggest the possible mechanism of GO’s cytotoxicity as
follows: GO in medium attach to the surface of human
cells, providing a stimuli signal to the cells. The signal is
transduced inside the cells and the nucleus, leading to
down-regulation of adhesion-associated genes and corre-
sponding adhesive proteins, resulting in decrease in cell
adhesion and causing cells to detach, float, and shrink
in size. At the same time, GO enters into cytoplasm by
endocytosis pathway, mainly located in the lysosomes,
mitochondrion, endoplasm and cell nucleus, may disturb
the course of cell energy metabolism and gene transcrip-
tion and translation, and finally result in cell apoptosis
or death.
The Possible Mechanism of Effects of GO on Mice
As we observed, graphene oxides under low dose
(0.1 mg) and middle dose (0.25 mg) did not exhibit
obvious toxicity to mice, under high dose (0.4 mg)
exhibited chronic toxicity such as 4/9 mice death and
lung granuloma formation, mainly located in lung, liver,
spleen and kidney, almost could not be cleaned by kid-
ney. The possible mechanism of effects of GO on mice
is suggested as follows: when GO enters into mouse
body by vessel injection, directly enter into blood circu-
lation system, as one kind of foreign body, which should
be recognized and tracked by immune cells, GO quickly
distributes into lung, liver, spleen, and kidney, but can-
not enter into brain due to blood–brain barrier. When
GO enters into lung tissues, provides a stimulating sig-
nal to lung cells, under synergic action of lung cells and
immune cells, GO is captured and wrapped by immune
cells, finally results in lung granuloma formation, GO in
liver, spleen, and kidney may cause corresponding
inflammation. Because of flake-shapes of GO, GO is
very difficult to be kicked out by kidney, thus stay in
liver, spleen, and kidney for long term, at the lower
Figure 8 TEM images of the ultrastructural features of the lung and live tissue: a lung tissue, b live tissue, arrows point to GO.
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dose, these organs such as liver, spleen, and kidney can
tolerate and maintain their normal function, at higher
dose, lot of GO in liver, spleen, and kidney can damage
the balance and badly affect the function of these
organs, result in failure of organ function and death of
mice. Regarding the effects of immune cells on GO in
vivo in mice, the possible mechanism is not clarified
well and still needs further research.
Conclusion
In conclusion, our primary studies have indicated that
GO could produce cytotoxicity in dose- and time-
dependent means, and can enter into cytoplasm and
nucleus, decreasing cell adhesion, inducing cell floating
and apoptosis. GO can enter into lung tissues and stop
there and induce lung inflammation and subsequent
granulomas highly dependent on injected dose. Expo-
sures to GO may induce severe cytotoxicity and lung
diseases. It should be the first report. Although GO has
been investigated for biomedical applications such as
cell imaging and drug delivery [30-35], because of GO’s
long-term stay in kidney and being very difficult to be
cleaned by kidney, therefore, GO may not own good
application prospect in human body. How to decrease
or abolish the toxicity of GO is still a challengeable task
for in vivo biomedical application. Further work will
focus on investigating the possible mechanism of inter-
action between GO and immune cells in human body
or mice.
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